A new treatment listed on the Pharmaceutical Benefits Scheme is said to reduce the recurrence of melanoma for half of stage three cancer patients.
Share
LIVE, FREE and EXCLUSIVE

Acral lentiginous melanoma of the sole, level 1. Source: Getty Images
Published
By Abby Dinham
Presented by Nikki Canning
Source: SBS
Share this with family and friends

